The LLS Blog
Read about survivors, research, fundraising and advocacy.
Meet The Researcher: Dr. Rayne Rouce
To commemorate Black History Month, LLS is highlighting exceptional clinicians and healthcare professionals throughout the month of February. Dr. Rayne Rouce is a physician at Texas Children's Cancer Center where she is a member of the Leukemia/Lymphoma/Bone Marrow Transplant/Stem Cell Transplant Program. Dr. Rouce is board certified in pediatrics and pediatric hematology/oncology by the American Board of Pediatrics.
Burlington Stores & its Customers Raise Nearly $4 Million for LLS in the Fight Against Blood Cancer
The Leukemia & Lymphoma Society (LLS), the global leader in the fight against blood cancer, and Burlington Stores, the national retailer delivering amazing deals to customers every time they shop, teamed up for the 19th consecutive year to raise critical funds to support LLS’s goal of creating a world without blood cancer, and to furthering their LLS Children’s Initiative, a $100 million multi-year endeavor to help children not only survive, but thrive after treatment.
Take Part in the Raise Hope, End Cancer Fundraiser with Walgreens
Walgreens, The Leukemia & Lymphoma Society (LLS), and Susan G. Komen (Komen) are collaborating to raise funds to enable new research in breast and blood cancers and expand access, treatment, and support services for those living with these diseases. In 2019, Walgreens pledged to contribute more than $25 million to LLS and Komen collectively over the next five years to improve the health and well-being of people living with cancer nationwide. But we can’t do this alone.
LLS Celebrates New Drug Approval for a Rare Form of Childhood Cancer
At The Leukemia & Lymphoma Society (LLS), we celebrate every advancement toward our mission of curing blood cancer and improving the quality of life for patients and their families. Today’s reason to celebrate is the news that the U.S. Food and Drug Administration (FDA) has approved a new treatment for children with a rare type of cancer called ALK-positive anaplastic large cell lymphoma (ALCL).
Practicing Self-Advocacy During My PTCL Journey
The LLS Blog invites Aaron, who was diagnosed with peripheral T-cell lymphoma (PTCL), to share his reflections on becoming a self-advocate throughout his cancer experience. Read his powerful first-hand account